CrunchBase is hiring! Check out our open positions →
Register | Login or Login

Exit

Acquired byTakeda Pharmaceutical
Price$310M
Date12/11

General Information

Websiteintellikine.com
CategoryBioTech
Phone858.768.6500
Employees
DescriptionOncology Pharmaceuticals

Offices

La Jolla, USA
10931 N. Torrey Pines Rd., Suite 103
La Jolla, CA, 92037
USA

Funding

TOTAL $85M
FUNDING TOTAL $85M
Series B, 6/07
Sofinnova Ventures
$30M
Series B, 7/09
Novartis Venture Funds
US Venture Partners
Biogen Idec
Abingworth
CMEA Capital
Sofinnova Ventures
$51M
Venture Round, 10/11
$4M

Tags

Intellikine

Intellikine works in the discovery and development of novel, small molecule therapies targeting the PI3K/Akt/mTOR pathway.

Intellikine is committed to building an exceptional team and a powerful discovery platform that rapidly generates small molecule kinase inhibitor drug candidates that will become the next generation of medical breakthroughs.

Recent Milestones

Videos

Screenshots

Intellikine screenshot
Above: Intellikine
Uploaded: 11/2/11

Sources

  1. Takeda to Acquire Intellikine, Adding Two Novel Programs to its Oncology Pipeline (intellikine.com) [edit]
  2. EDGAR [edit]
  3. Intellikine, Inc.: Series B $51M (onbiovc.com) [edit]
  4. Intellikine Reaps $4M In Milestone Payments (fis.dowjones.com) [edit]
Edit This Page
Last Edited 12/21/11

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

Recent Incoming Links

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy